Prostaglandin analogues are first-line therapeutic options to treat elevated intraocular pressure (IOP) in open-angle glaucoma (OAG) or ocular hypertension (OH).1
Saflutan eye drops (Tafluprost) preservative-free prostaglandin analogue treats IOP and OH. It also lowers the risk of developing symptoms of ocular surface disease, such as irritation, burning, itching, tearing or dry eye sensation, which may be experienced by patients using preservative eye drops to manage this life-long condition.2
Saflutan eye drops offer:
- Optimal IOP control: reduction of IOP starts between two and four hours after the first administration, and maximum effect is reached at around 12 hours after instillation. The duration of effect is maintained for at least 24 hours.3
- Significantly improved ocular symptoms and signs in patients switched from latanoprost.4
Saflutan eye drops is listed on the PBS as a drug for open angle glaucoma or ocular hypertension. Available as a sterile, preservative-free solution in single dose containers (0.3ml) containing 4.5 micrograms of tafluprost (0.0015%).1
Contact: Mundipharma (AUS) 1800 188 009
- Saflutan eye drops Product Information, July 2020
- Perez-Roca F, Rodrigo-Morales E, Garzon I, et al. Effects of four formulations of prostaglandin analogs on eye surface cells. A comparative study. PLoS One. 2015;10(6):e0129419. doi: 10.1371/journal.pone.0129419.
- Uusitalo H, Pillunat LE, Ropo A. Efficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open-angle glaucoma and ocular hypertension: 24-month results of a randomized, double-masked phase III study. Acta Ophthalmol. 2010;88:12-19.
- Uusitalo H, Chen E, Pfeiffer N, et al. Switching from a preserve to a preservative-free prostaglandin preparation in topical glaucoma medication. Acta Ophthalmol. 2010;88:329-336.